# Risk: __Limited data and sample size__ (PBN__Risk_1661)

## Property: has_RiskISO_Impact

* [Innovation, Creativity and research](../RiskISO/PBN__RiskISO_Purpose_2)

## Property: has_RiskTechnology

* [data collection tools](../Technology/PBN__Technology_1003)
* [research methodologies](../Technology/PBN__Technology_899)

## Property: has_RiskSubject

* [study participants](../Stakeholder/PBN__Stakeholder_1093)
* [researchers](../Stakeholder/PBN__Stakeholder_2)

## Property: has_RiskType

* [nan](../RiskType/PBN__RiskType_14)

## Property: has_RiskISO_Purpose

* [Resilience](../RiskISO/PBN__RiskISO_Impact_2)

## Property: has_RiskOwner

* [researchers](../Stakeholder/PBN__Stakeholder_2)
* [funding agencies](../Stakeholder/PBN__Stakeholder_996)

## Property: has_RiskMitigation

* [Collect more data, conduct larger studies for more solid conclusions](../RiskMitigation/PBN__RiskMitigation_2216)

## Property: has_RiskName

Limited understanding, uncertainty in findings

## Property: has_RiskDescription

Intrinsic limitations of studies including small sample sizes and lack of data, leading to challenges in drawing solid conclusions.

## Property: has_RiskSource

* [lodder_sars-cov-2_2020](../Article/PBN__Article_70)

## Property: has_RiskGBN

* [nan](../RiskGBN/PBN__RiskGBN_2)

## Property: has_RiskHealth

* [nan](../RiskHealth/PBN__RiskHealth_6)

